Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00808808 · ClinicalTrials.gov registry record
Assessing Choice in the Employer Setting (ACES) Study
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 4,411
- Enrollment target
NCT00808808: Completed study, sponsored by MedImmune.
NCT00808808 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 4,411 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00808808 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 4,411 participants
- Enrollment target
Study Summary
The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.
Interventions
- BIOLOGICAL Choice of TIV or FluMist with baseline advertisement
- OTHER Choice of TIV or FluMist with enhanced advertisement and incentives
- BIOLOGICAL Control - Usual care offering TIV only with baseline advertisement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,411 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-12 |
What the finished NCT00808808 record still lists
NCT00808808 is an observational study that tracks outcomes without assigning an intervention. Its 4,411 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Choice of TIV or FluMist with baseline advertisement is the first listed.
NCT00808808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00808808 about?
NCT00808808 is a clinical study titled "Assessing Choice in the Employer Setting (ACES) Study". The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.
What is the current status of trial NCT00808808?
This trial is currently completed. The enrollment target is 4,411 participants. The study started on 2008-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00808808?
The interventions under investigation include: Choice of TIV or FluMist with baseline advertisement (BIOLOGICAL), Choice of TIV or FluMist with enhanced advertisement and incentives (OTHER), Control - Usual care offering TIV only with baseline advertisement (BIOLOGICAL).
Who is sponsoring clinical trial NCT00808808?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02660645 · 4,400 participants
Blue Light Cystoscopy With Cysview® Registry
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia